Medications
Show
- Cancer
- KSQ Boosts PARP Inhibition In Models Of Cancer With USP1 Inhibitor
- Interrupting DNA repair in cancer cells via multiple pathways could help to overcome drug resistance in breast and ovarian cancers.
- 384 0
- Medications
- Low-Dose Naltrexone, Endorphins, and the Brain
- When it was introduced in the mid-1980s, naltrexone was used for blocking opioid receptors.
- 333 0
- Addiction
- OxyContin Maker Agrees To Billion Dollar Settlement For Role In Opioid Crisis
- Purdue Pharma, the maker of OxyContin has agreed to pay an $8 billion settlement for its role in the opioid crisis
- 645 0
- Pain Management
- Are You Making Pain Treatment Mistakes?
- When chronic pain just doesn’t seem to want to go away, you may need to rethink your treatment approach
- 633 0
-
- Cancer
- KSQ Boosts PARP Inhibition In Models Of Cancer With USP1 Inhibitor
- Interrupting DNA repair in cancer cells via multiple pathways could help to overcome drug resistance in breast and ovarian cancers.
- 384 0
-
- Medications
- Low-Dose Naltrexone, Endorphins, and the Brain
- When it was introduced in the mid-1980s, naltrexone was used for blocking opioid receptors.
- 333 0
-
- Addiction
- OxyContin Maker Agrees To Billion Dollar Settlement For Role In Opioid Crisis
- Purdue Pharma, the maker of OxyContin has agreed to pay an $8 billion settlement for its role in the opioid crisis
- 645 0
-
- Pain Management
- Are You Making Pain Treatment Mistakes?
- When chronic pain just doesn’t seem to want to go away, you may need to rethink your treatment approach
- 633 0
Load More
